Etomidate is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Etomidate.
Product ID | 65219-445_2dce5018-4fbd-49ab-8647-1d00f8f5cb90 |
NDC | 65219-445 |
Product Type | Human Prescription Drug |
Proprietary Name | Etomidate |
Generic Name | Etomidate |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2021-08-01 |
Marketing Category | ANDA / |
Application Number | ANDA215028 |
Labeler Name | Fresenius Kabi USA, LLC |
Substance Name | ETOMIDATE |
Active Ingredient Strength | 2 mg/mL |
Pharm Classes | General Anesthesia [PE],General Anesthetic [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2021-08-01 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0143-9310 | Etomidate | Etomidate |
0143-9311 | Etomidate | Etomidate |
0143-9506 | Etomidate | Etomidate |
0143-9507 | Etomidate | Etomidate |
23155-160 | Etomidate | Etomidate |
23155-522 | Etomidate | Etomidate |
25021-674 | etomidate | etomidate |
51662-1485 | ETOMIDATE | ETOMIDATE |
51662-1542 | ETOMIDATE | ETOMIDATE |
55150-221 | ETOMIDATE | ETOMIDATE |
55150-222 | ETOMIDATE | ETOMIDATE |
65145-127 | Etomidate | Etomidate |
65145-128 | Etomidate | Etomidate |
65219-445 | Etomidate | Etomidate |
65219-447 | Etomidate | Etomidate |
65841-818 | etomidate | etomidate |
67457-902 | Etomidate | Etomidate |
67457-903 | Etomidate | Etomidate |
68083-234 | Etomidate | Etomidate Injection |
68083-235 | Etomidate | Etomidate Injection |
68382-545 | etomidate | etomidate |
70518-1003 | Etomidate | Etomidate |
70860-652 | Etomidate | Etomidate |
72266-146 | Etomidate | Etomidate |
72266-147 | Etomidate | Etomidate |
0404-9811 | Amidate | Etomidate |
0409-6695 | Amidate | ETOMIDATE |
0409-8060 | Amidate | Etomidate |
52584-695 | Amidate | Etomidate |